Effect of tree nuts on glycemic control in diabetes: A systematic review and meta-analysis of randomized controlled dietary trials

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Viguiliouk, Effie ^a,b   Kendall, Cyril W C ^a,b,e   Mejia, Sonia Blanco ^a,b   Cozma, Adrian I ^a,b   Ha, Vanessa ^a,b   Mirrahimi, Arash ^a,b,f   Jayalath, Viranda H ^a,g   Augustin, Livia S A ^a,b   Chiavaroli, Laura ^a,b   Leiter, Lawrence A ^a,b,d   De Souza, Russell J ^a,b,c   Jenkins, David J A ^a,b,d   Sievenpiper, John L ^a,c,d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

^f QUEEN S UNIVERSITY   (Canada)

^g UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

CALORIC INTAKE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; DISEASE MARKER; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUT; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT DURATION; TREE NUT; BLOOD; DIET SUPPLEMENTATION; DIET THERAPY; GLUCOSE BLOOD LEVEL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FASTING; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; NUTS; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84905046621     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103376     Document Type: Review

References (59)

1. Ros E (2010) Health benefits of nut consumption. Nutrients 2(7): 652-682.
2. Kris-Etherton PM, Hu FB, Ros E, Sabaté J (2008) The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr 138(9): 1746S-1751S.
3. Salas-Salvadó J, Bulló M, Perez-Heras A, Ros E (2006) Dietary fibre, nuts and cardiovascular diseases. Br J Nutr 96 Suppl 2: S46-51.
4. Bulló M, Lamuela-Raventós R, Salas-Salvadó J (2011) Mediterranean diet and oxidation: nuts and olive oil as important sources of fat and antioxidants. Curr Top Med Chem 11(14): 1797-1810.
5. Segura R, Javierre C, Lizarraga MA, Ros E (2006) Other relevant components of nuts: phytosterols, folate and minerals. Br J Nutr 96 Suppl 2: S36-44.
6. Bao Y, Han J, Hu FB, Giovannucci EL, Stampfer MJ, et al. (2013) Association of nut consumption with total and cause-specific mortality. N Engl J Med 369(21): 2001-2011.
7. Luo C, Zhang Y, Ding Y, Shan Z, Chen S, et al. (2014) Nut consumption and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis. Am J Clin Nutr. [Epub ahead of print]
8. Sabaté J, Oda K, Ros E (2010) Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med 170(9): 821-827.
9. US Food and Drug Administration (FDA). Qualified health claims: Letter of enforcement discretion-nuts and coronary heart disease (Docket No 02P-0505) [accessed June 4 2014]. Available from: http://www.fda.gov/food/ ingredientspackaginglabeling/labelingnutrition/ucm072926.htm.
10. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, et al. (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114(1): 82-96. (Pubitemid 44305278)
11. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106(25): 3143-3421.
12. Pan A SQ MJ, Willett WC, Hu FB (2013) Walnut consumption is associated with lower risk of type 2 diabetes in women. The Journal of Nutrition 143(4): 512-518.
13. Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, et al. (2002) Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 288(20): 2554-2560. (Pubitemid 35386890)
14. Kochar J, Gaziano JM, Djousse L (2010) Nut consumption and risk of type II diabetes in the Physicians' Health Study. Eur J Clin Nutr 64(1): 75-79.
15. Parker ED, Harnack LJ, Folsom AR (2003) Nut consumption and risk of type 2 diabetes. JAMA 290(1): 38-39; author reply 39-40.
16. Zhou D YH, He F, Reilly KH, Zhang J, Li S, Zhang T, Wang B, Ding Y, Xi B (2014) Nut consumption in relation to cardiovascular risk and type 2 diabetes: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. [Epub ahead of print].
17. Salas-Salvado J, Bullo M, Estruch R, Ros E, Covas MI, et al. (2014) Prevention of Diabetes With Mediterranean Diets A Subgroup Analysis of a Randomized Trial. Ann Intern Med 160(1): 1-10.
18. Mann JI, De Leeuw I, Hermansen K, Karamanos B, Karlstrom B, et al. (2004) Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14(6): 373-394. (Pubitemid 40459260)
19. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, et al. (2013) Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 36(11): 3821-3842.
20. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee (2013) Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes (suppl 1): S1-S212.
21. Kendall CW, Josse AR, Esfahani A, Jenkins DJ (2010) Nuts, metabolic syndrome and diabetes. Br J Nutr 104(4): 465-473.
22. Salas-Salvadó J, Martinez-González MÁ, Bulló M, Ros E (2011) The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis 21 Suppl 2: B32-48.
23. Higgins JPT Green S (editors) (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from: www.cochrane-handbook.org.
24. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7): e1000097.
25. Alasalvar C, Shahidi F (2009) Tree nuts : composition, phytochemicals, and health effects. Boca Raton: CRC Press.
26. Heyland DK NF, Drover JW, Jain M, Su X, Suchner U (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 286(8): 944-953. (Pubitemid 33010341)
27. Lovejoy JC, Most MM, Lefevre M, Greenway FL, Rood JC (2002) Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr 76(5): 1000-1006. (Pubitemid 35244670)
28. Wien MA, Sabate JM, Ikle DN, Cole SE, Kandeel FR (2003) Almonds vs complex carbohydrates in a weight reduction program. Int J Obes Relat Metab Disord 27(11): 1365-1372. (Pubitemid 37386486)
29. Sauder KA, McCrea CE, Kris-Etherton PM, Ulbrecht JS, West SG (2013) Effect of pistachios on lipids, lipoproteins, glucose metabolism, and insulin sensitivity in type 2 diabetes. FASEB Journal 2013 27: 368.4.
30. Cohen AE, Johnston CS (2011) Almond ingestion at mealtime reduces postprandial glycemia and chronic ingestion reduces hemoglobin A(1c) in individuals with well-controlled type 2 diabetes mellitus. Metabolism-Clinical and Experimental 60(9): 1312-1317.
31. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, et al. (2002) Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 31(1): 140-149. (Pubitemid 34284916)
32. Darvish Damavandi R SF, Rajab A, Mohammadi V, Hosseini Sh (2012) The effects cashew consumption on serum glucose, insulin and lipoprotein in type 2 diabetic patients. Iranian Journal of Endocrinology and Metabolism 14(4): 325-334.
33. Jenkins DJA, Kendall CWC, Banach MS, Srichaikul K, Vidgen E, et al. (2011) Nuts as a Replacement for Carbohydrates in the Diabetic Diet. Diabetes Care 34(8): 1706-1711.
34. Li SC, Liu YH, Liu JF, Chang WH, Chen CM, et al. (2011) Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism-Clinical and Experimental 60(4): 474-479.
35. Ma Y, Njike VY, Millet J, Dutta S, Doughty K, et al. (2010) Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial. Diabetes Care 33(2): 227-232.
36. Tapsell LC, Batterham MJ, Teuss G, Tan SY, Dalton S, et al. (2009) Long-term effects of increased dietary polyunsaturated fat from walnuts on metabolic parameters in type II diabetes. Eur J Clin Nutr 63(8): 1008-1015.
37. Tapsell LC, Gillen LJ, Patch CS, Batterham M, Owen A, et al. (2004) Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 27(12): 2777-2783. (Pubitemid 39565036)
38. Damavandi RD ES, Shidfar F, Heydari I, Foroushani AR. (2013) Effects of hazelnuts consumption on fasting blood sugar and lipoproteins in patients with type 2 diabetes. J Res Med Sci 18(4): 314-321.
39. Esposito K, Maiorino MI, Ceriello A, Giugliano D (2010) Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review. Diabetes Res Clin Pract 89(2): 97-102.
40. Esposito K, Maiorino MI, Ciotola M, Di Palo C, Scognamiglio P, et al. (2009) Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Ann Intern Med 151(5): 306-314.
41. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, et al. (2008) Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359(3): 229-241. (Pubitemid 352008438)
42. Elhayany A, Lustman A, Abel R, Attal-Singer J, Vinker S (2010) A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. Diabetes Obes Metab 12(3): 204-209.
43. Singh RB, Dubnov G, Niaz MA, Ghosh S, Singh R, et al. (2002) Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet 360(9344): 1455-1461. (Pubitemid 35356323)
44. Sievenpiper JL, Dworatzek PD (2013) Food and dietary pattern-based recommendations: an emerging approach to clinical practice guidelines for nutrition therapy in diabetes. Can J Diabetes 37(1): 51-57.
45. Lasa A, Miranda J, Bulló M, Casas R, Salas-Salvadó J, et al. (2014) Comparative effect of two Mediterranean diets versus a low-fat diet on glycaemic control in individuals with type 2 diabetes. Eur J Clin Nutr. [Epub ahead of print].
46. Azadbakht L FN, Karimi M, Baghaei MH, Surkan PJ, Rahimi M, Esmaillzadeh A, Willett WC. (2011) Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes Care 34(1): 55-57.
47. US Food and Drug Administration (FDA) (2009) Guidance for Industry: A Food Labeling Guide [accessed June 4 2014]. Available from: http://www.fda.gov/ food/guidanceregulation/guidancedocumentsregulatoryinformation/ labelingnutrition/ucm2006828.htm
48. Dong JY, Xun P, He K, Qin LQ (2011) Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 34(9): 2116-2122.
49. Larsson SC, Wolk A (2007) Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med 262(2): 208-214. (Pubitemid 47087634)
50. Song Y, He K, Levitan EB, Manson JE, Liu S (2006) Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 23(10): 1050-1056. (Pubitemid 44401132)
51. Casas-Agustench P, Bulló M, Salas-Salvadó J (2010) Nuts, inflammation and insulin resistance. Asia Pac J Clin Nutr 19(1): 124-130.
52. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, et al. (2003) Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 24(1-3): 39-52. (Pubitemid 36092143)
53. Suárez A PN, Casla A, Casanova B, Arrieta FJ, Rovira A. (1995) Impaired tyrosine-kinase activity of muscle insulin receptors form hypomagnesaemia rats. Diabetologia 38(11): 1262-1270.
54. Schwingshackl L, Strasser B, Hoffmann G (2011) Effects of monounsaturated fatty acids on glycaemic control in patients with abnormal glucose metabolism: a systematic review and meta-analysis. Ann Nutr Metab 58(4): 290-296.
55. Lopez S, Bermudez B, Ortega A, Varela LM, Pacheco YM, Villar J, Abia R, Muriana FJ (2011) Effects of meals rich in either monounsaturated or saturated fat on lipid concentrations and on insulin secretion and action in subjects with high fasting triglyceride concentrations. Am J Clin Nutr 93(3): 494-499.
56. Moon JH, Lee JY, Kang SB, Park JS, Lee BW, Kang ES, Ahn CW, Lee HC, Cha BS (2010) Dietary monounsaturated fatty acids but not saturated fatty acids preserve the insulin signaling pathway via IRS-1/PI3K in rat skeletal muscle. Lipids 45(12): 1109-1116.
57. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9): 1462-1470. (Pubitemid 29418240)
58. Saudek CD, Kalyani RR, Derr RL (2005) Assessment of glycemia in diabetes mellitus: hemoglobin A1c. J Assoc Physicians India 53: 299-305. (Pubitemid 41280087)
59. U.S. Department of Agriculture, Agricultural Research Service (2013) USDA National Nutrient Database for Standard Reference, Release 14. Nutrient Data Laboratory Home Page, http://www.ars.usda.gov/ba/bhnrc/ndl